[Radiosensitization by paclitaxel. The in-vivo results in paclitaxel-sensitive and -resistant tumors].
Vogt
H G
HG
Zamboglou
N
N
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use* / Q000633:toxicity; D003131:Combined Modality Therapy; D004354:Drug Screening Assays, Antitumor; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000532:radiotherapy*; D017239:Paclitaxel / Q000627:therapeutic use* / Q000633:toxicity; D011836:Radiation Tolerance / Q000187:drug effects*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use* / Q000633:toxicity
D000972:Antineoplastic Agents, Phytogenic; D011838:Radiation-Sensitizing Agents; D017239:Paclitaxel